ArticleRSC advances2026

Development, anti-proliferative activity, multi-target kinase inhibition against CHK1, PIM1, and CDK-2, and computational insights of new thiazole-based hybrids.

Najla A Altwaijry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.